Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa

Dissertation (MSc)--University of Pretoria, 2010.

Saved in:
Bibliographic Details
Other Authors: Cromarty, Allan Duncan
Format: Thesis
Published: University of Pretoria 2013
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613453193052161
access_status_str Open Access
author2 Cromarty, Allan Duncan
author_browse Cromarty, Allan Duncan
author_facet Cromarty, Allan Duncan
collection Thesis
dc_rights_str_mv © 2009, University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria.
description Dissertation (MSc)--University of Pretoria, 2010.
format Thesis
id oai:repository.up.ac.za:2263/27974
institution University of Pretoria (South Africa)
last_indexed 2026-06-10T12:36:23.211Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2013
publishDateRange 2013
publishDateSort 2013
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/27974 The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa Cromarty, Allan Duncan wahoch@gmail.com Hochfeld, Warren Ernst Patients Symptomatic treatments South Africa (SA) Parkinson’s disease (PD) UCTD Dissertation (MSc)--University of Pretoria, 2010. Parkinson’s disease (PD) impairs the quality of life of patients and causes substantial social and economic burden. However the currently available symptomatic treatments, although initially effective, do not satisfactorily control the progressive disability experienced by patients with PD in the long run. In order to develop effective treatments for patients that aim to attain the desired effect with as few adverse events as possible, it is crucial to be able to follow and understand the biological mechanisms underlying the continued neural degeneration and treatment failure. The efforts to understand the precise pathway by which neurodegenerative processes proceed and the development of approaches to modulate them offers the promise to eventually enable the prevention of these neurodegenerative diseases. This dissertation focused on two potential synthetic methods to produce pharmaceutical grade Fluorodopa, ultimately to be able to produce positron emitting 18Fluorodopa in South Africa with its potential for studying neuronal mechanisms in the brain. 18Fluorodopa allows a unique almost non-invasive in vivo approach to the evaluation of neurochemical function in the human brain and its local introduction will be a valuable addition to medical research within South Africa’s borders. The successful implementation of safe and efficient non-radioactive models for Fluorodopa synthesis was achieved. The successful demonstration of locally synthesised Fluorodopa safety, as well as a low toxicity profile, both in vitro using cell cultures and in vivo in mouse models was achieved. These were both positive outcomes of objectives set out for this study. Copyright Pharmacology unrestricted 2013-09-07T12:40:18Z 2010-09-16 2013-09-07T12:40:18Z 2010-04-16 2010-09-16 2010-09-16 Dissertation Hochfeld, WE 2009, The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa, MSc dissertation, University of Pretoria, Pretoria, viewed yymmdd < http://hdl.handle.net/2263/27974 > E10/248/gm http://hdl.handle.net/2263/27974 http://upetd.up.ac.za/thesis/available/etd-09162010-151505/ © 2009, University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria
spellingShingle Patients
Symptomatic treatments
South Africa (SA)
Parkinson’s disease (PD)
UCTD
The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa
title The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa
title_full The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa
title_fullStr The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa
title_full_unstemmed The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa
title_short The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa
title_sort chemical synthesis pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography pet brain imaging in south africa
topic Patients
Symptomatic treatments
South Africa (SA)
Parkinson’s disease (PD)
UCTD
url http://hdl.handle.net/2263/27974
http://upetd.up.ac.za/thesis/available/etd-09162010-151505/